Provided by Tiger Trade Technology Pte. Ltd.

Legend Biotech

19.32
-0.5700-2.87%
Post-market: 19.15-0.1654-0.86%19:41 EDT
Volume:2.22M
Turnover:43.06M
Market Cap:3.76B
PE:-38.58
High:19.78
Open:19.61
Low:19.19
Close:19.89
52wk High:37.50
52wk Low:16.24
Shares:194.49M
Float Shares:91.34M
Volume Ratio:1.13
T/O Rate:2.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5008
EPS(LYR):-1.6200
ROE:-8.08%
ROA:-1.92%
PB:3.06
PE(LYR):-11.93

Loading ...

Legend Biotech Carvykti Growth, Profitability Outlook Remain Positive, RBC Says

MT Newswires Live
·
Aug 12

Legend Biotech Price Target Cut to $58.00/Share from $59.00 by RBC Capital

Dow Jones
·
Aug 12

Legend Biotech Corp. : Oppenheimer Cuts to Perform from Outperform

THOMSON REUTERS
·
Aug 12

Goldman Sachs Reaffirms Their Buy Rating on Legend Biotech (LEGN)

TIPRANKS
·
Aug 12

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Brookdale Senior Living (BKD) and Legend Biotech (LEGN)

TIPRANKS
·
Aug 12

RBC Adjusts Price Target on Legend Biotech to $58 From $59, Maintains Outperform Rating

MT Newswires Live
·
Aug 12

U.S. Research Roundup-Cardinal Health, Lumentum Holdings, Public Storage

Reuters
·
Aug 12

Legend Biotech Corporation : TD Cowen Cuts Target Price to $24 from $29

THOMSON REUTERS
·
Aug 12

TD Cowen Sticks to Its Hold Rating for Legend Biotech (LEGN)

TIPRANKS
·
Aug 12

Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Legend Biotech (LEGN) and Sagimet Biosciences, Inc. Class A (SGMT)

TIPRANKS
·
Aug 12

U.S. Stocks on the MOVEX-Abbott, Columbia Financial, Jabil,

Reuters
·
Aug 11

Legend Biotech Shares Rise After Swinging to 2Q Profit, Higher Revenue

Dow Jones
·
Aug 11

U.S. Stocks on the MOVE-Duke Energy, Sea, Cardinal Health

Reuters
·
Aug 11

GenScript Biotech Announces Legend Biotech Form 6-K for Q2 Ended June 30, 2026

Reuters
·
Aug 11

Legend Biotech Rises After Second Quarter Results Beat Estimates

Reuters
·
Aug 11

Legend Biotech Shares Rise 4.1% Premarket After Q2 Revenue Beat

THOMSON REUTERS
·
Aug 11

Legend Biotech Q2 Revenue Beats Estimates on Commercial Expansion

Reuters
·
Aug 11

Legend Biotech Q2 FY26 Turns to Net Income of $33.2 Million; Revenue Rises 51.9% to $387.5 Million Year over Year

Reuters
·
Aug 11

Legend Biotech Q2 Adj. EPS $0.16 Beats $0.07 Estimate, Sales $387.500M Beat $355.772M Estimate

Benzinga Earnings
·
Aug 11

Legend Biotech Corporation - Carvykti Net Trade Sales Increase 50% in Q2 2026 to $657 Mln

THOMSON REUTERS
·
Aug 11